Loading
BB Biotech AG Stock: price and insider trades · Switzerland
No insider purchase over the last 90 days. The latest was filed 05 Mar 2025.
BB Biotech AG: what insiders have been doing
This page follows insider dealings at BB Biotech AG as filed with SIX SER, a company from the Health Care sector based in Schaffhausen, Switzerland. The group dates from 1993. BB Biotech AG has had no insider filing for more than a year; the last one goes back to 5 March 2025.
These figures are compiled from regulatory filings published by SIX SER. They describe what insiders did and are not a recommendation.
Insider Decl.
7
Thresholds
n/a
Buy Volume
€1M
7 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleAnonymous (Non-executive member of the board of directors)1 buy
Analyst consensus: bullish or bearish?
Analysts rate BB Biotech AG Strong Buy (bullish), based on 2 analysts. Average price target: CHF 69.00.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 22 of 24,148 companies
95.0
score / 100
Value91
Quality99
FCF yld12%
Earn yld22%
EV/EBITDA·
ROE55%
Gross mgn·
Net mgn98%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CHF 52.00
Analyst consensus
2 analystsStrong buy
CHF 65.00Target CHF 69.00(+33%)CHF 73.00
Income statement
RevenueCHF 587M
Net incomeCHF 578.1M98.5% margin
Valuation
PER (trailing)2.1x
PER (forward)-78.9x
P/Book1.1x
Beta0.65
Balance sheet & cash
Market capCHF 2.9B
Total debtCHF 117.5M
Free Cash FlowCHF 309.1M
Profitability & ownership
ROE34.9%
ROA15.9%
% insiders0.1%
% institutions18.7%
Last declaration on 5 March 2025
Declarations7 total
1,112 shares@ CHF 36.7753.4% of flowISIN CH0038389992SIX:T1P3500081
Canonical exit: 3 Jun 2025 (T+90)
1,244 shares@ CHF 37.86433.9% of flowISIN CH0038389992SIX:T1O9G000J8
Canonical exit: 15 Dec 2024 (T+90)
1,244 shares@ CHF 44.14274.5% of flowISIN CH0038389992SIX:T1O7T000C0
Canonical exit: 27 Oct 2024 (T+90)
1,000 shares@ CHF 41.453.3% of flowISIN CH0038389992SIX:T1O4U000Q0
Canonical exit: 29 Jul 2024 (T+90)
1,200 shares@ CHF 45.97294.4% of flowISIN CH0038389992SIX:T1O3P00084
Canonical exit: 23 Jun 2024 (T+90)
2,200 shares@ CHF 48.14878.5% of flowISIN CH0038389992SIX:T1O3M00099
Canonical exit: 20 Jun 2024 (T+90)
17,750 shares@ CHF 49.282672.0% of flowISIN CH0038389992SIX:T1O2G00044
Canonical exit: 16 May 2024 (T+90)
7 of 7 declarations
About BB Biotech AG
BB Biotech AG is an investment company focused on the healthcare and pharmaceutical sector. It is listed on the Swiss Stock Exchange (XSWX).
